要闻 来源:格隆汇 时间:2026-05-15 18:04:59
【资料图】
格隆汇5月15日丨昂利康(002940.SZ)公布,收到国家药品监督管理局(简称“国家药监局”)签发的瑞舒伐他汀依折麦布片(I)《药品注册证书》,瑞舒伐他汀依折麦布片(I)主要用于治疗高胆固醇血症以及纯合子型家族性高胆固醇血症(HoFH)。
上一篇:南向资金净买入额突破80亿港元
下一篇:最后一页
26-05-14
26-05-14
26-05-13
26-05-13
26-05-13
26-05-12
26-05-12
26-05-12
26-05-11
26-05-11
26-05-12
26-05-12
26-05-12
26-05-12
26-05-12
26-05-12
26-05-12
26-05-12
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-11
26-05-10
26-05-10
26-05-10
26-05-10
26-05-10
26-05-10
26-05-10
26-05-10
26-05-10
26-05-10
22-09-30
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
26-05-15
26-05-15
26-05-15
26-05-14
26-05-14
26-05-14
26-05-13
26-05-13
26-05-13
26-05-12
23-07-10
